Global Value Dossiers (GVD)
As a strategic reference, the Global Value Dossier (GVD) consolidates clinical, economic, and value-based evidence to support HTA submissions, market access, and pricing decisions worldwide. We are aware of the various challenges that may arise aligning regulatory requirements, market needs, and internal objectives from an early stage. Our experience in clinical development, with German and European HTA submissions and with economic value proposition for pricing purposes shows that successful dossiers require close cross-functional collaboration and consistency across all related documents and communications.
The GVD aligns internal teams – medical affairs, market access, HEOR, and commercial – around a shared understanding of product value. It forms the foundation for local dossiers, HTA engagements, and reimbursement decisions across diverse healthcare systems. With high-quality evidence and aligned messaging, the GVD reduces duplication and ensures local adaptations are built on a strong global framework.
Ready to strengthen your product’s value story? Contact us for a tailored GVD concept or a portfolio-wide strategic roll out.
Dr. Jana Maurer
Deputy Director Medical Science
Jana began her career with a Ph.D. (Dr. rer. nat.) in basic research on chronic inflammatory bowel diseases at the Technical University of Munich. Since 2014, she has been a leading expert in strategic consulting and Medical Writing at AMS, with a particular focus on Health Technology Assessment (HTA), including EU HTA and AMNOG. There she provides strategic guidance to companies in developing product-specific market access strategies and supports the preparation of HTA dossiers for pharmaceuticals and medical devices in various indications, such as oncology and chronic inflammatory diseases. As a Senior Medical Writer, she leverages her expertise in writing and presentation to communicate scientific content with clarity and precision - ranging from HTA dossiers and peer-reviewed publications to oral and poster presentations. With over 20 years of experience in leading interdisciplinary teams, she has successfully managed the Medical Writing and EU HTA teams at AMS. From 2015 to 2017, she also headed the Market Access Group for medical devices, focusing on reimbursement strategies in Germany. Since 2022, as Deputy Director of the Medical Science department, she has been responsible for business & strategy development and client relations.
Our service expert
Dr. Jana Maurer
Deputy Director Medical Science
Our services include
GVD concept & content development
The respective GVD format and structure will be developed, and key value messages will be aligned.
GVD writing
Co-creation of high-quality, well-aligned global value narrative.
Systematic/targeted literature research (SLR/TLR)
Searches on relevant GVD aspects, such as disease burden, epidemiology, treatment options, unmet medical need, and health economic models provide sound and up to date evidence.
HTA review and benchmarking
Review and summary of HTA reports and reimbursement decisions to inform positioning and messaging.
Training session (roll out) on how to use the GVD
We offer training sessions and support your internal adoption of the GVD.
Possible modules:
- Introduction & Overview to the GVD structure and content
- Key value messages per section
- Customization guidance for specific markets/local adaptations
- New layer of GVD content: integrating several PICOs, ITC feasiblity – JCA dossier perspective
References
